Mohammad A. Mohey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mohammad A. Mohey has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
Gamal Esmat
Faculty Of Medicine, Cairo University, Cairo, Egypt
3 shared publicationsAhmed Fouad
Department of Endemic Medicine and Hepatology, Faculty of Medicine, Cairo University, Cairo, Egypt
1 shared publication- Ahmed Ihab Abdelaziz
School of Medicine, Newgiza University (NGU), Giza 12577, Egypt
1 shared publication Amira Bassam
Pathology Department, Faculty of Medicine, Cairo University, Cairo, Egypt
1 shared publicationAmr Abul-Fotouh
Department of Endemic Medicine and Hepatology, Faculty of Medicine, Cairo University, Cairo, Egypt
1 shared publication- Ayatollah El-Shorbagy
Departments of Zoology and Entomology, Faculty of Science, Helwan University, Cairo, Egypt
1 shared publication
Latest Publications
- 12 December 2016
- Published by Wiley in Parasite Immunology
- Vol. 39 (1)
Protective role ofIL‐22 againstSchistosoma mansonisoluble egg antigen‐induced granuloma in Vitro
Summary: The role of T helper‐17 (Th17) lymphocytes in the regulation ofSchistosoma mansonisoluble egg antigen (SEA)‐induced granuloma is unknown. This study examined the effect of Th17 cytokines (IL‐17 andIL‐22) on granulocyte recruitment and functions duringSEA‐induced granuloma formation in vitro inSchistosoma‐infected and noninfected individuals. Granulocytes were isolated from 27Schistosoma‐infectedpatients and 13 controls and were used for granuloma induction usingSEA‐conjugated polyacrylamide beads in the presence of Th17 cytokines. Granuloma index was assessed, and granulocyte mediators such as tumour necrosis factor (TNF‐α), hydrogen peroxide (H2O2) and nitric oxide (NO) were measured in the culture supernatant at the 7th day using enzyme‐linked immunosorbent assay (ELISA).Schistosoma‐infectedpatients had significant largerSEA‐induced granuloma than controls.IL‐17 (125 pg/mL) induced the optimum size for granuloma within 3‐7 days. However,IL‐22 at different concentrations up to 300 pg/mL had no effect on granuloma formation. Using both cytokines simultaneously,IL‐22 suppressed the effect ofIL‐17 and prevented granuloma formation.IL‐17 significantly decreasedTNF‐α, H2O2andNOlevels inSchistosoma‐infected individuals. In contrast,IL‐22 increasedTNF‐α and H2O2levels. In conclusion,IL‐17 acceleratesSEA‐induced granuloma formation and inhibits granulocytes functions inSchistosoma‐infected patients, whileIL‐22 inhibited the granuloma formation, but enhanced granulocyte functions.
- 12 December 2016
- Published by Wiley in Parasite Immunology
- Vol. 39 (1)
Protective role ofIL‐22 againstSchistosoma mansonisoluble egg antigen‐induced granuloma in Vitro
Summary: The role of T helper‐17 (Th17) lymphocytes in the regulation ofSchistosoma mansonisoluble egg antigen (SEA)‐induced granuloma is unknown. This study examined the effect of Th17 cytokines (IL‐17 andIL‐22) on granulocyte recruitment and functions duringSEA‐induced granuloma formation in vitro inSchistosoma‐infected and noninfected individuals. Granulocytes were isolated from 27Schistosoma‐infectedpatients and 13 controls and were used for granuloma induction usingSEA‐conjugated polyacrylamide beads in the presence of Th17 cytokines. Granuloma index was assessed, and granulocyte mediators such as tumour necrosis factor (TNF‐α), hydrogen peroxide (H2O2) and nitric oxide (NO) were measured in the culture supernatant at the 7th day using enzyme‐linked immunosorbent assay (ELISA).Schistosoma‐infectedpatients had significant largerSEA‐induced granuloma than controls.IL‐17 (125 pg/mL) induced the optimum size for granuloma within 3‐7 days. However,IL‐22 at different concentrations up to 300 pg/mL had no effect on granuloma formation. Using both cytokines simultaneously,IL‐22 suppressed the effect ofIL‐17 and prevented granuloma formation.IL‐17 significantly decreasedTNF‐α, H2O2andNOlevels inSchistosoma‐infected individuals. In contrast,IL‐22 increasedTNF‐α and H2O2levels. In conclusion,IL‐17 acceleratesSEA‐induced granuloma formation and inhibits granulocytes functions inSchistosoma‐infected patients, whileIL‐22 inhibited the granuloma formation, but enhanced granulocyte functions.
- 1 September 2016
- Published by Elsevier in The Lancet Gastroenterology & Hepatology
- Vol. 1 (1) , 36-44
Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trial
- 1 September 2016
- Published by Elsevier in The Lancet Gastroenterology & Hepatology
- Vol. 1 (1) , 36-44
Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trial
- 1 June 2016
- Published by Elsevier in Arab Journal of Gastroenterology
- Vol. 17 (2) , 90-94
Study of the clinical relevance of Helicobacter pylori virulence genes to gastric diseases among Egyptian patients
- 1 June 2016
- Published by Elsevier in Arab Journal of Gastroenterology
- Vol. 17 (2) , 90-94
Study of the clinical relevance of Helicobacter pylori virulence genes to gastric diseases among Egyptian patients
- 1 January 2016
- Published by Elsevier in Immunology Letters
- Vol. 169, 52-60
Contradicting roles of miR-182 in both NK cells and their host target hepatocytes in HCV
- 1 January 2016
- Published by Elsevier in Immunology Letters
- Vol. 169, 52-60
Contradicting roles of miR-182 in both NK cells and their host target hepatocytes in HCV
- 1 June 2015
- Published by Elsevier in Arab Journal of Gastroenterology
- Vol. 16 (2) , 50-53
Relation of ALT and AST levels to the histopathological changes in liver biopsies of patients with chronic hepatitis C genotype 4
- 1 June 2015
- Published by Elsevier in Arab Journal of Gastroenterology
- Vol. 16 (2) , 50-53
Relation of ALT and AST levels to the histopathological changes in liver biopsies of patients with chronic hepatitis C genotype 4
- 2 July 2014
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 21 (12) , 956-964
CUFA algorithm: assessment of liver fibrosis using routine laboratory data
Summary: Staging of liver fibrosis is an integral part of the management of HCV. Liver biopsy is hampered by its invasiveness and possibility of sampling error. Current noninvasive methods are disadvantaged by their cost and complexity. In this study, we aimed at developing a noninvasive method for the staging of liver fibrosis based only on routine laboratory tests and clinical data. Basic clinical and laboratory data and liver biopsies were collected from 994 patients presenting for the evaluation of HCV. Logistic regression was used to create a model predictive of fibrosis stages. A sequential test was then developed by combining our new model with APRI. In the training set (497) a model was created by logistic regression for the prediction of significant fibrosis (≥F2), it included platelets, AST and age (PLASA). The areas under the curve (AUC), sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were 0.753, 66.8, 71.4, 69.8, 68.4, respectively, while in the validation set (497), they were 0.777, 66.7, 72.8, 68.6 and 71, respectively. These were the best performance indicators when compared to APRI, FIB‐4, King's score, platelets, fibrosis index, age–platelet index and Lok index in the same set of patients. A sequential test was then developed including APRI followed by PLASA [Cairo University Fibrosis Assessment (CUFA) algorithm], this allowed saving 20% and 34% of liver biopsies for patients being tested for significant fibrosis and cirrhosis, respectively. In conclusion, the CUFA algorithms at no cost allow saving a significant proportion of patients from performing a liver biopsy or a more complex costly test. These algorithms could be used as the first step in the assessment of liver fibrosis before embarking on the more costly advanced serum markers, Fibroscan or liver biopsy.
- 2 July 2014
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 21 (12) , 956-964
CUFA algorithm: assessment of liver fibrosis using routine laboratory data
Summary: Staging of liver fibrosis is an integral part of the management of HCV. Liver biopsy is hampered by its invasiveness and possibility of sampling error. Current noninvasive methods are disadvantaged by their cost and complexity. In this study, we aimed at developing a noninvasive method for the staging of liver fibrosis based only on routine laboratory tests and clinical data. Basic clinical and laboratory data and liver biopsies were collected from 994 patients presenting for the evaluation of HCV. Logistic regression was used to create a model predictive of fibrosis stages. A sequential test was then developed by combining our new model with APRI. In the training set (497) a model was created by logistic regression for the prediction of significant fibrosis (≥F2), it included platelets, AST and age (PLASA). The areas under the curve (AUC), sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were 0.753, 66.8, 71.4, 69.8, 68.4, respectively, while in the validation set (497), they were 0.777, 66.7, 72.8, 68.6 and 71, respectively. These were the best performance indicators when compared to APRI, FIB‐4, King's score, platelets, fibrosis index, age–platelet index and Lok index in the same set of patients. A sequential test was then developed including APRI followed by PLASA [Cairo University Fibrosis Assessment (CUFA) algorithm], this allowed saving 20% and 34% of liver biopsies for patients being tested for significant fibrosis and cirrhosis, respectively. In conclusion, the CUFA algorithms at no cost allow saving a significant proportion of patients from performing a liver biopsy or a more complex costly test. These algorithms could be used as the first step in the assessment of liver fibrosis before embarking on the more costly advanced serum markers, Fibroscan or liver biopsy.
- Open Access
- 1 January 2013
- Published by Medknow in Saudi Journal of Gastroenterology
- Vol. 19 (4) , 177-81
The first Egyptian experience using new self-expandable metal stents in acute esophageal variceal bleeding: Pilot study
Background / Aim: Balloon tamponade has been widely available in emergency situations of acute variceal bleeding. To lessen the complications of Balloon tamponade, a new special type of stent for exclusive use in acute variceal bleeding has been developed. This study aims to investigate the effectiveness and safety of the new self-expandable metal stents (SEMS) in the initial control of acute variceal bleeding. We also hypothesized that using SEMS can bridge the acute bleeding episode converting endoscopic management by sclerotherapy or band ligation to an elective procedure. Patients and Methods: Twenty patients with acute variceal bleeding were included in the study and 16 of them were allocated to receive stent treatment. Results: Stent deployment was successful in 15 of 16 patients (93.75%). Technical errors were reported in 3 (18.75%) patients. Initial control of variceal bleeding was reported in 14 (out of 16) (87.5%) patients. The mean duration of the procedure was 10 (±6) min. Mortality was reported in 4 (25.0%) patients. Conclusion: SEMS is a safe and effective mean to control acute variceal bleeding.
- 1 January 2013
- Published by Medknow in Saudi Journal of Gastroenterology
- Vol. 19 (4) , 177-81
Open AccessThe first Egyptian experience using new self-expandable metal stents in acute esophageal variceal bleeding: Pilot study
Background / Aim: Balloon tamponade has been widely available in emergency situations of acute variceal bleeding. To lessen the complications of Balloon tamponade, a new special type of stent for exclusive use in acute variceal bleeding has been developed. This study aims to investigate the effectiveness and safety of the new self-expandable metal stents (SEMS) in the initial control of acute variceal bleeding. We also hypothesized that using SEMS can bridge the acute bleeding episode converting endoscopic management by sclerotherapy or band ligation to an elective procedure. Patients and Methods: Twenty patients with acute variceal bleeding were included in the study and 16 of them were allocated to receive stent treatment. Results: Stent deployment was successful in 15 of 16 patients (93.75%). Technical errors were reported in 3 (18.75%) patients. Initial control of variceal bleeding was reported in 14 (out of 16) (87.5%) patients. The mean duration of the procedure was 10 (±6) min. Mortality was reported in 4 (25.0%) patients. Conclusion: SEMS is a safe and effective mean to control acute variceal bleeding.